NewsDesk @bactiman63 Researchers from the University of Georgia have discovered a potential treatment for Chagas disease, marking the first medication with promise to successfully and safely target the...

Researchers at Karolinska Institutet in Sweden have mapped how the parasite Trypanosoma cruzi forms new variants that are more effective at evading the immune system and causing disease. Their findings...

According to estimates by the World Health Organization (WHO), between six and seven million people worldwide, predominantly in Central and South America, are infected with the Trypanosoma cruzi species...

NewsDesk @bactiman63 More than 50,000 people in Spain live with Chagas , of which 613 are children, according to estimates from an analysis led by the Barcelona Institute for Global Health (ISGlobal),...

By NewsDesk  @infectiousdiseasenews In search of treatment for Chagas disease, which kills thousands each year, Cal State Fullerton infectious disease researchers have discovered an important new mechanism...

By NewsDesk  @bactiman63 Wednesday was World Chagas Disease Day and the Pan American Health Organization (PAHO) discussed in a press release a number of data of the parasitic disease in the Americas. One...

Animal toxins are research targets owing to their therapeutic and biotechnological potential. Researchers at the Federal University of the ABC (UFABC), Federal University of São Paulo (UNIFESP) and Federal...

By NewsDesk  @bactiman63 New insight on how a parasite can resist current therapies has been published in the open-access eLife journal. The study in cultures of human cells infected with Trypanosoma...

Chagas disease is a potentially life-threatening parasitic disease that affects  up to 300,000 people in the United States and millions in South America. The current treatment regimen is–oral benznidazole...

By NewsDesk  @bactiman63 Researchers in the University of Georgia’s Center for Tropical and Emerging Global Diseases have found that a more intensive, less frequent drug regimen with currently...